WSJ News Exclusive | Johnson & Johnson’s Talc Plan Spotlights Chapter 11 Voting Power
Johnson & Johnson’s latest plan to resolve mass cancer lawsuits through bankruptcy could force some cosmetic-talc users and their lawyers...
Johnson & Johnson’s latest plan to resolve mass cancer lawsuits through bankruptcy could force some cosmetic-talc users and their lawyers...
Rome CNN — Pope Francis showed a “clear improvement” on Thursday after being given intravenous antibiotics for a bronchitis infection...
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose...
PoliticsHealth PolicyPoor internal communication hindered FDA’s response to crisis, former deputy commissioner says Source link
Kroger and Albertsons want to merge in a $20 billion deal. If antitrust regulators approve, the definition of a grocery...
BusinessHealth CareHealthCovis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works...
Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales. Source link
The growing conflict between China and the U.S. extends from computer-chip factories to a suspected spy balloon over American skies....
BusinessInquiries from agencies come amid criminal investigation by Justice Department into company’s formula manufacturing Source link
CNN — Members of Congress are urging Secretary of State Antony Blinken to pressure China to do more to curb...
HealthEzriCare nonprescription drops may have contained drug-resistant bacteria Source link
A federal appeals court in Philadelphia rejected Johnson & Johnson ‘s use of chapter 11 bankruptcy to freeze roughly 40,000...
BusinessHealth CareHealthDrugmakers can limit shipments to hospitals and clinics of drugs discounted under federal program, court rules in loss for...
The new Prime membership benefit, dubbed RxPass, will offer unlimited access to commonly prescribed generic medications. Source link
The company said it would apply in coming months for U.S. regulatory approval. Source link
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
The Drug Enforcement Administration told makers of medication for attention-deficit hyperactivity disorder that it was concerned that “aggressive marketing practices”...
New Delhi CNN — The Indian maker of a cough syrup linked to at least 18 deaths in Uzbekistan has...
HealthDoctors, pharmacists ask the FDA to stop the sale of versions of Benadryl, Mucinex, Theraflu and Tylenol after studies find...
BusinessThe U.S. biotechnology company will pay $116.50 for each Horizon share Source link